Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Seer, Inc./ 8-K

Current Report · Items 8.01, 9.01 · 8-K

Seer, Inc.

SEERNASDAQEQUITYCurrent

Other Events

Item 8.01 Other Events. On July 20, 2026, Seer, Inc. issued a press release concerning the unsolicited, non-binding acquisition proposal received from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, on July 1, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Filed Jul 20, 2026Accepted Jul 20, 2026, 4:08 PM EDTCIK 1726445Accession 0001193125-26-308919
View company →Permanent SEC source ↗
Share

Company context

Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

Current securities

SEERNASDAQ · EQUITY · Current

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 18, 2026
  2. 10-Q filingAug 11, 2026
  3. Results of Operations and Financial ConditionAug 11, 2026
  4. Submission of Matters to a Vote of Security HoldersJul 31, 2026
  5. Other EventsJul 31, 2026

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On July 20, 2026, Seer, Inc. issued a press release concerning the unsolicited, non-binding acquisition proposal received from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, on July 1, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Filed exhibits (1)
EX-99.1 (by filename) d105079dex991.htm

EX-99.1 2 d105079dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. REDWOOD CITY, Calif., July 20, 2026 (GLOBE NEWSWIRE) - Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors, consisting of independent directors Meeta Gulyani and Nicolas Roelofs, Ph. D., has thoroughly reviewed and unanimously rejected the unsolicited, non-binding proposal received on July 1, 2026, from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights (the “Proposal”). Consistent with its fiduciary duties, the Special Committee carefully reviewed the Proposal in consultation with its independent advisors and unanimously determined that it is not in the best interests of Seer’s stockholders because it undervalues Seer and fails to reflect the value of Seer’s long-term growth prospects. In reaching this conclusion, the Special…

Open exhibit ↗